Results 11 to 20 of about 8,194 (217)
A phenomap of TTR amyloidosis to aid diagnostic screening
ESC Heart FailureCardiac amyloidosis due to transthyretin (ATTR) remains an underdiagnosed cause of cardiomyopathy. As awareness of the disease grows and referrals for ATTR increase, clinicians are likely to encounter more atypical forms of the condition in clinical ...
Alexios S. Antonopoulos +4 more
doaj +2 more sources
ESC Heart FailureAims Data on the clinical profiles of patients with transthyretin amyloidosis cardiomyopathy (ATTR‐CM) in the post‐approval era of tafamidis 61 mg are lacking.
Richard J. Nies +23 more
doaj +2 more sources
Nature Communications, 2019 Systemic amyloidosis of the ATTR is one of the most abundant forms of systemic amyloidosis and caused by misfolding of the circulating blood protein transthyretin (TTR).
Matthias Schmidt +2 more
exaly +2 more sources
Impact of Earlier Diagnosis in Cardiac ATTR Amyloidosis Over the Course of 20 Years [PDF]
Circulation, 2022 Adam Ioannou +2 more
exaly +2 more sources
Transthyretin Kinetic Stabilizers for ATTR Amyloidosis. [PDF]
Cardiol TherKelly JW.
europepmc +2 more sources
A case of cardiac amyloidosis incidentally detected by bone scintigraphy [PDF]
Asia Oceania Journal of Nuclear Medicine and Biology, 2021 A 73-year-old man with lung cancer underwent bone scintigraphy for disease staging. Diffuse myocardial technetium hydroxymethylene diphosphonate (99mTc-HMDP) uptake was incidentally found.
Hiroki Tanaka +7 more
doaj +1 more source
Cardiac microcalcifications in transthyretin (ATTR) amyloidosis [PDF]
International Journal of Cardiology, 2022 Bone tracers bind to amyloid-containing heart of most patients with ATTR amyloidosis. Amyloid deposits outside the heart are often scarce and bone scintigraphy is increasingly often used to diagnose cardiac involvement. However, the nature of the binding of bone tracers to the heart is not clear.To identify possible calcium deposits in hearts with ...
Ulrika, Thelander +6 more
openaire +2 more sources
ESC Heart Failure, 2021 Aims The aim of this study was to examine the prevalence of amyloid transthyretin (ATTR) cardiac amyloidosis in patients 1–2 years after trans‐catheter aortic valve replacement (TAVR) and to assess their clinical and echocardiographic outcome and long ...
Sara Shimoni +9 more
doaj +1 more source
Diflunisal for ATTR Cardiac Amyloidosis [PDF]
Congestive Heart Failure, 2012 ©2012 Wiley Periodicals Inc.Transthyretin (TTR) cardiac amyloidosis is an important, often under‐recognized and potentially modifiable cause of heart failure with a preserved ejection fraction. The only proven treatment is liver or combined heart/liver transplantation, which, although effective, is not suitable for the vast majority of older adults ...
Adam, Castaño +4 more
openaire +2 more sources
Structural polymorphism of amyloid fibrils in ATTR amyloidosis revealed by cryo-electron microscopy [PDF]
Nature CommunicationsVirender Singh, , Andrew Lemoff
exaly +2 more sources